National Medical Care Company

SASE:4005 株式レポート

時価総額：ر.س7.4b

National Medical Care 将来の成長

Future 基準チェック /26

National Medical Care利益と収益がそれぞれ年間11.2%と12.7%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に19.5% 11.8%なると予測されています。

主要情報

11.2%

収益成長率

11.8%

EPS成長率

Healthcare 収益成長15.5%
収益成長率12.7%
将来の株主資本利益率19.5%
アナリストカバレッジ

Good

最終更新日09 Dec 2024

今後の成長に関する最新情報

Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Aug 06
Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Recent updates

What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You

Dec 12
What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You

National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

Oct 29
National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue

Sep 25
National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue

Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Aug 06
Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely

Jul 26
Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely

National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

Apr 05
National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

Mar 14
We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Mar 13
National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Dec 27
Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

Dec 05
Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Aug 07
We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

May 29
Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

May 08
Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Dec 19
Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Oct 19
A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

Aug 15
National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

May 13
National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 03
Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Feb 10
A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down

Nov 10
Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down

Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes

Jul 02
Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes

Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)

Apr 14
Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)

Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?

Mar 25
Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?

Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?

Feb 23
Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?

Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

Feb 09
Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 27
National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

Jan 14
Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

Dec 25
Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 10
Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

Nov 24
What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

業績と収益の成長予測

SASE:4005 - アナリストの将来予測と過去の財務データ ( )SAR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20261,7203812754736
12/31/20251,5483392023956
12/31/20241,278294-222305
9/30/20241,221274-322-85N/A
6/30/20241,171288-13488N/A
3/31/20241,119266212423N/A
12/31/20231,082241412467N/A
9/30/20231,034233838704N/A
6/30/2023997202670531N/A
3/31/2023968196349386N/A
12/31/2022918170185217N/A
9/30/2022882151-16252N/A
6/30/2022857142-12686N/A
3/31/2022843131845N/A
12/31/20218451365694N/A
9/30/20218441225894N/A
6/30/20218451051549N/A
3/31/20218281001740N/A
12/31/20208099788107N/A
9/30/202078095187198N/A
6/30/202074095216225N/A
3/31/202072483155162N/A
12/31/201970880152162N/A
9/30/201970565236246N/A
6/30/201970760245259N/A
3/31/201973767188206N/A
12/31/201876462299318N/A
9/30/201881081199231N/A
6/30/201884296N/A236N/A
3/31/201885995N/A279N/A
12/31/201785585N/A113N/A
9/30/2017817-8N/A-9N/A
6/30/2017806-7N/A70N/A
3/31/201784933N/A72N/A
12/31/201690150N/A103N/A
9/30/2016931155N/A87N/A
6/30/2016945153N/A63N/A
3/31/2016913136N/A77N/A
12/31/2015879131N/A51N/A
9/30/2015853106N/A127N/A
6/30/2015820102N/A80N/A
3/31/201577291N/A38N/A
12/31/201473495N/A71N/A
9/30/2014703106N/A32N/A
6/30/2014660103N/A15N/A
3/31/201462394N/A75N/A
12/31/201358692N/A79N/A

アナリストによる今後の成長予測

収入対貯蓄率: 4005の予測収益成長率 (年間11.2% ) は 貯蓄率 ( 14.7% ) を下回っています。

収益対市場: 4005の収益 ( 11.2% ) はSA市場 ( 5.9% ) よりも速いペースで成長すると予測されています。

高成長収益: 4005の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 4005の収益 ( 12.7% ) SA市場 ( -0.6% ) よりも速いペースで成長すると予測されています。

高い収益成長: 4005の収益 ( 12.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 4005の 自己資本利益率 は、3年後には低くなると予測されています ( 19.5 %)。

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2024/12/22 16:18
終値2024/12/22 00:00
収益2024/09/30
年間収益2023/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を例とし、非米国証券については同等の規制書式と情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

National Medical Care Company 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12

アナリスト機関
Ibrahim ElaiwatAljazira Capital Company
Jassim Al-JubranAljazira Capital Company
Madhu AppissaAl Rajhi Capital